AL
SGMO

Airain Ltd’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Airain Ltd’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-28,737
Closed -$310K – 893
2014
Q3 		$310K Sell
28,737
-17,971
-38% -$235K 0.02% 573
2014
Q2 		$713K Buy
+46,708
New +$672K 0.06% 339
2013
Q4 		– Sell
-13,268
Closed -$139K – 688
2013
Q3 		$139K Buy
+13,268
New +$132K 0.03% 421

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Airain Ltd's SGMO Position: Q4 2014 in Review

Airain Ltd sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2014, closing a stake of 28,737 shares — an estimated $310K sold.

Airain Ltd first reported a position in SGMO in Q3 2013 and held it in 3 quarters. The position peaked at $713K in Q2 2014. 158 funds tracked by Wall St. Rank hold SGMO as of Q4 2014.

  • Airain Ltd reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2014 after selling out during the quarter.
  • Airain Ltd sold 28,737 SANGAMO THERAPEUTICS INC shares in Q4 2014, an estimated $310K.
  • Airain Ltd first reported a position in SANGAMO THERAPEUTICS INC in Q3 2013 and held it in 3 quarters.
  • Airain Ltd's SANGAMO THERAPEUTICS INC position peaked at $713K in Q2 2014.
  • 158 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2014.

Based on Airain Ltd's 13F filing for Q4 2014, filed 12 Feb 2015.